Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients
Open Access
- 5 August 2024
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (12) , 8372-8382
Abstract
Background: Recommendations for breast surveillance following breast plastic surgery are frequently changing. Establishing guidelines for long-term monitoring protocols may help identify treatable conditions and prevent untoward sequelae. We sought to evaluate the current state of evidence-based long-term monitoring protocols for patients following breast augmentation, reduction, and breast reconstruction. Methods: Official guidelines from various American societies and international societies were analyzed for alignment in evidence-based recommendations regarding breast surveillance. Results: The most recent US FDA update recommends magnetic resonance imaging or ultrasound starting 5–6 years after surgery and every 2–3 years thereafter. Discrepancies exist among professional societies: the American Society of Plastic Surgeons (ASPS) aligns with the FDA, while the American Society of Breast Surgeons and American College of Radiology (ACR) find no role for imaging for asymptomatic cases. Ultrasound is first-line for any implant concerns, with MRI if necessary. European societies oppose routine breast implant imaging. Breast reduction patients lack unique screening protocols; monitoring aligns with age and cancer risk factors. Following mastectomy and breast reconstruction, most organizations advocate for annual clinical examinations, with more frequent examinations initially. Evidence suggests that physical examination is sufficient to detect local cancer recurrence, with imaging only indicated if there is concern for recurrence. No surveillance imaging is recommended by the American Society of Clinical Oncology, National Comprehensive Cancer Network, or ASPS; however, ACR recommends mammography for autologous reconstruction only. Conclusion: Multispecialty and regulatory body alignment may promote provider and patient adherence. Ongoing studies of long-term outcomes are needed to strengthen the level of evidence for monitoring guidelines.Keywords
This publication has 108 references indexed in Scilit:
- EBV-Positive Diffuse Large B-Cell Lymphoma in Association with Polyurethane Textured Breast Implants: Case Report and Literature OverviewAesthetic Plastic Surgery, 2023
- Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction—A systematic review and meta‐analysisCancer, 2022
- Use of Preoperative Mammography During Evaluation for Nononcologic Breast Reduction SurgeryJAMA Surgery, 2019
- Analysis of 109 Consecutive Explanted Breast Implants: Correlation Between Suspected Implant Rupture and Surgical FindingsAesthetic Plastic Surgery, 2016
- Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancerBreast Cancer Research and Treatment, 2015
- Qualitative mammographic findings and outcomes of surveillance mammography after partial breast reconstruction with an autologous flapJournal of Surgical Oncology, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- MRI screening for silicone breast implant rupture: accuracy, inter- and intraobserver variability using explantation results as reference standardEuropean Radiology, 2014
- Mammographic Findings Following Reduction MammoplastyAesthetic Plastic Surgery, 2001
- Detection of local recurrence after conservative therapy for breast carcinomaCancer, 1992